Published in Cell Death Differ on April 01, 2006
Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. Curr Cancer Drug Targets (2010) 1.07
Amelioration of central cardiovascular regulatory dysfunction by tropomyocin receptor kinase B in a mevinphos intoxication model of brain stem death. Br J Pharmacol (2011) 0.81
Secreted Glioblastoma Nanovesicles Contain Intracellular Signaling Proteins and Active Ras Incorporated in a Farnesylation-dependent Manner. J Biol Chem (2016) 0.75
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol (2011) 2.13
Optic neuropathy in patients with glioblastoma receiving bevacizumab. Neurology (2009) 1.84
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol (2001) 1.82
Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J Biol Chem (1998) 1.78
Fixed drug combinations and the displacement of bilirubin from albumin. Pediatrics (1971) 1.54
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44
The perception and practice of traditional medicine in the treatment of cancers and inflammations by the Hausa and Fulani tribes of Northern Nigeria. J Ethnopharmacol (2007) 1.34
Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J Biol Chem (1994) 1.28
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. Ann Oncol (2007) 1.24
In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms. Am J Pathol (1998) 1.21
Radiological aspects of intra-uterine blood transfusion. Br J Radiol (1967) 1.18
Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J Biol Chem (1997) 1.17
Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy. Arch Dis Child (1970) 1.15
Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery (1999) 1.12
Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes. J Pathol (2006) 1.10
The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway. Oncogene (2006) 1.10
Euphorbia hirta leaf extracts increase urine output and electrolytes in rats. J Ethnopharmacol (1999) 1.09
Monochorionic diamniotic minimally conjoined twins: a case report. Am J Med Genet (1990) 1.07
Metabolic aspects of the Beckwith-Wiedemann syndrome. J Pediatr (1973) 1.06
Complications of therapy for venous thromboembolic disease in patients with brain tumors. Neurology (1993) 1.05
Lipid metabolism in the neonate. II. The effect of Intralipid on bilirubin binding in vitro and in vivo. J Pediatr (1976) 1.03
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma. J Neurooncol (2011) 1.01
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol (1999) 1.01
Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response. Hum Gene Ther (2001) 0.99
Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg (1999) 0.98
Stromal inhibition of megakaryocytic differentiation correlates with blockade of signaling by protein kinase C-epsilon and ERK/MAPK. J Biol Chem (2001) 0.97
Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells. J Biol Chem (2000) 0.97
Chemical thermogenesis in newborn infants: catecholamine excretion and the plasma non-esterified fatty acid response to cold exposure. Pediatrics (1966) 0.96
Anticonvulsant activity of Carissa edulis (Vahl) (Apocynaceae) root bark extract. J Ethnopharmacol (2008) 0.96
Intramedullary spinal cord metastasis (ISCM) in renal cell carcinoma: a series of six cases. Ann Oncol (2001) 0.95
Quantitative analysis of cerebral asymmetries. Fronto-occipital correlation, sexual dimorphism and association with handedness. Arch Neurol (1986) 0.95
Central neurocytomas. Cancer (1997) 0.94
Sephadex G-25 quantitative estimation of free bilirubin potential in jaundiced newborn infants sera: a guide to the prevention of kernicterus. J Lab Clin Med (1972) 0.94
Metabolic effects of exchange transfusion. II. Delayed hypoglycemia following exchange transfusion with citrated blood. J Pediatr (1971) 0.94
Lipid metabolism in the neonate. I. The effects of Intralipid infusion on plasma triglyceride and free fatty acid concentrations in the neonate. J Pediatr (1976) 0.93
Venous thromboembolism in malignant gliomas. J Thromb Haemost (2009) 0.92
Low density lipoprotein receptor-related protein is expressed early and becomes restricted to a somatodendritic domain during neuronal differentiation in culture. Brain Res (1997) 0.92
Metabolic effects of exchange transfusions. I. Effect of citrated and of heparinized blood on glucose, nonesterified fatty acids, 2-(4 hydroxybenzeneazo) benzoic acid binding, and insulin. J Pediatr (1971) 0.90
The Meckel syndrome in the Hutterites. Am J Med Genet (1980) 0.90
Reye's syndrome in a newborn infant. Can Med Assoc J (1973) 0.87
Regulation of smooth muscle alpha-actin expression and hypertrophy in cultured mesangial cells. Kidney Int (1998) 0.87
Variance in albumin loading in exchange transfusions. J Pediatr (1976) 0.87
Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am J Transplant (2013) 0.87
Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response. Hum Gene Ther (2000) 0.86
Activated alpha 2-macroglobulin promotes mitogenesis in rat vascular smooth muscle cells by a mechanism that is independent of growth-factor-carrier activity. Eur J Biochem (1995) 0.86
Pertussis toxin activates platelets through an interaction with platelet glycoprotein Ib. Infect Immun (1994) 0.85
Neurologic perspectives of Crigler-Najjar syndrome type I. J Child Neurol (1998) 0.85
Insulin responses during catch-up growth of infants who were small for gestational age. Pediatrics (1976) 0.85
Analgesic effect of Irvingia gabonensis stem bark extract. J Ethnopharmacol (1995) 0.83
Plasma carnitine levels during intravenous feeding of the neonate. J Pediatr (1979) 0.83
The effect of intravenous glucagon on plasma amino acids in the newborn. Pediatr Res (1973) 0.82
Alpha 2-macroglobulin functions as a cytokine carrier to induce nitric oxide synthesis and cause nitric oxide-dependent cytotoxicity in the RAW 264.7 macrophage cell line. J Biol Chem (1995) 0.82
Competitive binding of free fatty acids and bilirubin to albumin: differences in HBABA dye versus sephadex G-25 interpretation of results. Clin Biochem (1971) 0.82
Modulatory effects of aluminum, calcium, lithium, magnesium, and zinc ions on [3H]MK-801 binding in human cerebral cortex. Brain Res (1989) 0.82
Elimination of ascorbic acid-induced membrane lipid peroxidation and serotonin receptor loss by Trolox-C, a water soluble analogue of vitamin E. J Recept Res (1992) 0.81
Osteoradionecrosis mimicking metastatic epidural spinal cord compression. Neurology (2005) 0.81
Behavioral properties of Balanites aegyptiaca in rodents. J Ethnopharmacol (2011) 0.81
Metabolic and growth patterns in transient neonatal diabetes. N Engl J Med (1972) 0.81
Renal clearance of digoxin in premature neonates. Res Commun Chem Pathol Pharmacol (1981) 0.80
Metastatic spinal cord compression in patients with colorectal cancer. J Neurooncol (1999) 0.79
Plasmin modulates the thrombin-evoked calcium response in C6 glioma cells. Biochem J (1994) 0.78
The clinical utility of Doppler ultrasound prior to arteriovenous fistula creation. Semin Dial (2001) 0.78
Pneumonic tularemia in a patient with chronic granulomatous disease. Clin Infect Dis (1997) 0.78
Safety assessment of the standardized extract of Carissa edulis root bark in rats. J Ethnopharmacol (2013) 0.78
Hypoglycemia and excretion of insulin in urine in hemolytic disease of the newborn. Pediatr Res (1970) 0.78
Gentamicin and albumin-bilirubin binding. An in vivo study. J Pediatr (1976) 0.78
Enhanced distress vocalization through selective reinforcement. Science (1966) 0.78
Lipid metabolism in the neonate. III. The ketogenic effect of Intralipid infusion in the neonate. J Pediatr (1978) 0.78
Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta. Oncogene (2006) 0.77
Independent efferent populations in the nucleus of the optic tract: an anatomical and physiological study in rat and cat. J Comp Neurol (1995) 0.77
Evaluation of the antipsychotic potential of aqueous fraction of Securinega virosa root bark extract in mice. Metab Brain Dis (2014) 0.77
Psychopharmacological potentials of methanol leaf extract of Securinega virosa Roxb (Ex Willd) Baill. in mice. Pak J Biol Sci (2014) 0.77
Behavioural effects of the methanolic root bark extract of Securinega virosa in rodents. Afr J Tradit Complement Altern Med (2008) 0.77
Bilirubin toxicity in a neuroblastoma cell line N-115: I. Effects on Na+K+ ATPase, [3H]-thymidine uptake, L-[35S]-methionine incorporation, and mitochondrial function. Pediatr Res (1989) 0.77
Neonatal jaundice and bilirubin encephalopathy: a clinical and experimental reappraisal. Isr J Med Sci (1992) 0.77
Bilirubin-neural cell interaction: characterization of initial cell surface binding leading to toxicity in the neuroblastoma cell line N-115. Biochim Biophys Acta (1990) 0.77
alpha 2-Macroglobulin synthesis by the human monocytic cell line THP-1 is differentiation state-dependent. J Cell Biochem (1997) 0.76
Bilirubin toxicity in neural cell lines N115 and NBR10A. Pediatr Res (1985) 0.76
Multiple-dose kinetics of digoxin in neonates. Pediatr Pharmacol (New York) (1985) 0.76
Partial trisomy 12p due to t(12;21)pat translocation. Hum Genet (1977) 0.76
Psychopharmacological properties of saponins from Randia nilotica stem bark. Pharm Biol (2013) 0.76
Angiotensin and drinking rates in the euryhaline killifish. Am J Physiol (1980) 0.76
Group B streptococcal infection in the newborn. Can Med Assoc J (1979) 0.75
Case 5-1995: arteritis with multiple cerebral infarcts. N Engl J Med (1995) 0.75
The internal environment of the baby with metabolic disturbances. Proc R Soc Med (1967) 0.75
Brain tumor patients with uncertain metastatic potential as organ donors in infancy and childhood. Klin Padiatr (2010) 0.75
Group B streptococcal infection in the newborn. Can Med Assoc J (1979) 0.75
Neonatal pneumopericardium. Can Med Assoc J (1975) 0.75
Effects of the platelet-activating factor receptor antagonist WEB 2086 on whole blood coagulation and fibrinolysis in a thromboelastography assay. Blood Coagul Fibrinolysis (1995) 0.75
Proceedings: Clinical implications of bilirubin-albumin binding in the newborn. Rev Can Biol (1973) 0.75
Letter: Competitive binding of plasma albumin by drugs and their vehicles and by bilirubin. J Pediatr (1975) 0.75
Effects on blood glucose, plasma insulin, growth hormone and alanine of different doses of glucagon on the first and third days of life. Isr J Med Sci (1972) 0.75
Diazepam (Valium) for neonatal narcotic withdrawal: a question of safety. Pediatrics (1972) 0.75
[Insulin secretion in children of diabetic mothers]. Union Med Can (1971) 0.75
Neonatal thrombocytopenia. J Pediatr (1971) 0.75
Neonatal thrombocytopenia and congenital malformations associated with administration of tolbutamide to the mother. J Pediatr (1970) 0.75